Source:http://www4.wiwiss.fu-berlin.de/dailymed/resource/drugs/3310
| Predicate | Object |
|---|---|
| rdf:type | |
| rdfs:label |
FROVA (Tablet, Film Coated)
|
| dailymed-instance:dosage |
The recommended dose is a single tablet of FROVA (frovatriptan 2.5 mg) taken orally with fluids. If the headache recurs after initial relief, a second tablet may be taken, providing there is an interval of at least 2 hours between doses. The total daily dose of frovatriptan should not exceed 3 tablets (3 x 2.5 mg per day). There is no evidence that a second dose of frovatriptan is effective in patients who do not respond to a first dose of the drug for the same headache. The safety of treating an average of more than 4 migraine attacks in a 30-day period has not been established.
|
| dailymed-instance:activeIng... | |
| dailymed-instance:activeMoi... | |
| dailymed-instance:inactiveI... |
dailymed-ingredient:colloidal_silicon_dioxide,
dailymed-ingredient:hydroxypropylmethylcellulose,
dailymed-ingredient:lactose,
dailymed-ingredient:magnesium_stearate,
dailymed-ingredient:microcrystalline_cellulose,
dailymed-ingredient:polyethylene_glycol_3000,
dailymed-ingredient:sodium_starch_glycolate,
dailymed-ingredient:titanium_dioxide,
dailymed-ingredient:triacetin
|
| dailymed-instance:genericMe... |
frovatriptan succinate
|
| dailymed-instance:fullName |
FROVA (Tablet, Film Coated)
|
| dailymed-instance:indicatio... |
FROVA is indicated for the acute treatment of migraine attacks with or without aura in adults. FROVA is not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine . The safety and effectiveness of FROVA have not been established for cluster headache, which is present in an older, predominately male, population.
|
| dailymed-instance:represent... | |
| dailymed-instance:routeOfAd... | |
| dailymed-instance:name |
FROVA
|